Help shape the first trials for the prevention of dementia with Lewy bodies and Parkinson’s disease! Investigators, at-risk advocates, and other stakeholders invested in preventing synucleinopathy are welcome to join in the exchange May 22–24, 2026 in Phoenix, Arizona at Planning for Prevention of Parkinson’s and Related Synucleinopathies: A trial design forum. This collaborative biennial conference focuses on advancing trial design research via its underlying biology and clinical science towards the prevention of DLB, PD, and related synucleinopathies, and will immediately precede the 2026 World Parkinson Congress.

Opportunities for participants include:

· Early bird registration
· Open abstract submissions, with eligible presenters considered for the Early-Career Investigator Travel Fellowship
· Limited hotel room block at a reduced nightly rate
· Networking across academic, advocacy, industry, & regulatory perspectives
· Mentorship program for Early-Career Investigators